• Activity Title

    Start Activity

    Understanding Thyroid Eye Disease - A Comprehensive Clinical Review

     

  • Description

    By the conclusion of this educational activity, participants should have a deeper understanding of Thyroid Eye Disease (TED). They should be able to distinguish that TED is diagnosed clinically, while Thyroid Disease is diagnosed biochemically. Furthermore, participants should be familiar with the signs and symptoms of TED, the clinical evaluation process for diagnosis, the current treatment options available, and the ongoing clinical trials aimed at enhancing and broadening treatment strategies for Thyroid Eye Disease.

  • Target Audience

    This activity is intended for clinical and scientific laboratory professionals, physician - scientists who have an interest in thyroid disease.

  • Learning Objectives

    After completing the activity, the participant should be better able to:

    • Explain the connection between thyroid dysfunction and Thyroid Eye Disease (TED).
    • Detail the development and progression of TED.
    • Recognize the signs and symptoms associated with TED.
    • Develop a diagnostic approach for TED.
    • Review the available treatment options for TED.

    Instruction Level: Intermediate

  • Speaker

    Jody G. Abrams, MD
    Neuro-Ophthalmologist and Oculoplastic Surgeon
    Sarasota Retina Institute
    Sarasota, Florida 

    Mark A. Lupo, MD
    Founder and Medical Director
    Thyroid & Endocrine Center of Florida
    Florida State University, College of Medicine
    Assistant Clinical Professor of Medicine
    Sarasota, Florida

  • Duration

    1.5 hours

  • Release and Expiration Dates

    Release Date: August 15, 2025
    Expiration Date: August 15, 2027

  • Disclosures

    The opinions expressed in the educational activity are those of the speaker and do not necessarily represent the views of any organization associated with this activity.

    Jody G. Abrams, MD
    -Consulting Fee (e.g., Advisory Board): Amgen/Horizon, Viridian
    -Contracted Research: Amgen/Horizon, Viridian
    -Speakers' Bureau: Amgen/Horizon, ANI

    Mark A. Lupo, MD
    -Consulting: Interpace Diagnostics, Elsai, Abbvie, Horizon Therapeutics
    -Contracted Research: Roche, QuidelOrtho, Takeda
    -Honoraria: Elsai, Interpace Diagnostics, Abbvie, QuidelOrtho
    -Speakers Bureau: Elsai, Interpace Diagnostics, Abbvie, QuidelOrtho

  • P.A.C.E.® Accreditation

    QuidelOrtho is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.

  • Start Activity

  • Policy on Privacy and Confidentiality

    QuidelOrtho Corporation protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. QuidelOrtho Corporation and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

    QuidelOrtho Corporation and its educational partners maintain physical, electronic and procedural safeguards that comply with recognized accreditation regulations to guard your non-public personal information.

  • Medium Used

    This program has been made available online.

  • Commercial Support Statement

    This activity is provided by the QuidelOrtho Corporation.

  • System Requirements

    To view this educational activity, you will need a modern web browser with JavaScript and HTML5. Cookies enabled allows users to proceed through all elements. Some users encounter issues with hand held devices ie. smart phones. In these cases, we recommend the use of computers.

  • Copyright

    Copyright © QuidelOrtho Corporation.

  • Web interface provided by Dane Garvin Ltd.

     

Contact Us